期刊文献+

新型抗结核药物的研究进展 被引量:8

下载PDF
导出
摘要 由于结核分枝杆菌耐药性的出现和艾滋病的蔓延,结核病已成为全球关注的健康问题,有效的控制结核病疫情仍然面临严峻的考验。本文主要介绍了抗结核新药的研究进展。
出处 《国外医药(抗生素分册)》 CAS 2006年第2期91-95,共5页 World Notes on Antibiotics
  • 相关文献

参考文献29

  • 1Payne D J, Warren PV, Holmes D J, et al. Bacterial fatty acid biosynthesis : a genomics-driven target for drug discovery [ J ]. Drug Discov Today,2001,6:537.
  • 2Editors. Advances in TB drug development [ J ], Scrip,2002,(2717) :20.
  • 3Mitscher LA, Baker W. Tuberculosis : a search for novel therapy starting with natural products [ J ]. Med Res Rev, 1998,18 (6) :363.
  • 4Ashtekar DR. In vitro and in vivo activities of the nitroimidazole CGI17341 against Mycobacterium tuberculosis [ J ]. Antimicrob Agents Chemother , 1993,37 : 183.
  • 5Stover CK, Warrener P, Donald R, et al. A smallmolecule nitroimidazopyran drug candidate for the treatment of tuberculosis [ J ]. Nature,2000,405:962.
  • 6Cynamon MH, Klemens SP, Sharpc CA, et al. Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model [J ]. Antimicrob Agents Chemother, 1999,43 : 1189.
  • 7Arima K, Imanaka H, Kousaka M, et al. Studies on pyrrolnitrin, a new antibiotic Isolation and properties of pyrrolnitrin [J]. J Antibiot (Tokyo) ,1965,18:201.
  • 8Jones BF,Parrish NM, Houston TA,et al. A new class of antituberculosis agents [ J ]. J Med Chem,2000 ,43 ( 17 ) :3304.
  • 9Andries K, Verhasselt P, Guillemont J, et a2. A diarylquinoline drug Active on the ATP synthase of Mymbaeterium tuberculosis [ J ]. Science,2005,307 :223.
  • 10侯丽莉.治疗肺结核的新武器?[J].国外医学(药学分册),2005,32(3):209-210. 被引量:4

二级参考文献43

  • 1端木宏谨.掌握结核病流行趋势,指导结核病防治工作[J].中华结核和呼吸杂志,2002,25(1):1-2.
  • 2谢惠安,阳国太,林善祥.现代结核病学[M].北京:人民卫生出版社,第一版,2001.510~544.
  • 3Ji B,Lounis N,Maslo C,et al.In vitro and in vivo activity of moxifloxacin and clinafloxacin against mycobacterium tuberculosis[J].Antimicrob Agents Chemother,1998,42(8):2066-2069.
  • 4Miyazaki E,Miyazaki M,Chen J M,et al.Moxifloxacin (BAY12-8039),a new 8-methoxyquinolone,is active in a mouse model of tuberculosis[J].Antimicrob Agents Chemother,1999,43(1):85-89.
  • 5Alvirez-Freites E J,Carter J L,Cynamon M H.In vitro and in vivo activities of gatifloxacin against mycobacterium tuberculosis[J].Antimicrob Agents Chemother,2002,46(4):1022-1025.
  • 6Zhao B Y,Pine R,Domagala J,et al.Fluoroquinolone action against clinical isolates of mycobacterium tuberculosis: effects of a C-8 methoxyl group on survival in liquid media and in human macrophages[J].Antimicrob Agents Chemother,1999,43(3):661-666.
  • 7Tomioka H,Sato K,Akaki T,et al.Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903,sitafloxacin (DU-6859a),gatifloxacin (AM-1155),and levofloxacin against mycobacterium tuberculosis and mycobacterium avium complex[J].Antimicrob Agents Chemother,1999,43(12):3001-3004.
  • 8Takahata M,Mitsuyama J,Yamashiro Y,et al.In vitro and in vivo antimicrobial activities of T-3811ME,a novel Des-F(6)-quinolone[J].Antimicrob Agents Chemother,1999,43(5):1077-1084.
  • 9Stover C K,Warrener P,VanDevanter D R,et al.A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis[J].Nature,2000,405(6789):962-969.
  • 10Baker WR,Shaopei C,Keeler EL.Nitro-[2,1-b]imidazopyran compounds and antibacterial uses[P].US:6087358,2000-07-11.

共引文献23

同被引文献99

引证文献8

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部